REGENXBIO Inc. ($RGNX)
Filing Information
| Accession Number | 0001700659-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
101,249
Total Value
$0.00
P&L
+inf% (+$820,116.90)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 6, 2026 | Grant/Award | 65,847 | $0.00 | $0.00 | 258,317 | Direct | โ | View Details | |
Chief Medical Officer | Stock Options (Right to buy) | Derivative | Jan 6, 2026 | Grant/Award | 35,402 | $0.00 | $0.00 | 35,402 | Direct | โ | View Details |